beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Term ID

CHEBI:132814

Synonyms

beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-D-Glc
beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
beta-D-galactosyl-(1-3)-N-acetyl-beta-D-galactosaminyl-(1-4)-beta-D-galactosyl-(1-4)-D-glucose
beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-D-glucose
Galbeta1-3GalNAcbeta1-4Galbeta1-4Glc

Definition

An amino tetrasaccharide consisting of β-D-galactose, N-acetyl-β-D-galactosamine, β-D-galactose and D-glucose residues in a linear (1→3), (1→4), (1→4) sequence.

References

glygen:G00407UJ
glytoucan:G00407UJ
pubmed:16406213

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Phenotype where environments contain beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Phenotype modified by environments containing beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Phenotype affecting beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Human Disease Model